|
Volumn 16, Issue 2, 2001, Pages 213-215
|
Glomerular hypertension - An under-appreciated aspect of chronic rejection
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 ETHYL 5,7 DIMETHYL 3 [4 [2 (2H TETRAZOL 5 YL)PHENYL]BENZYL]IMIDAZO[4,5 B]PYRIDINE;
ANGIOTENSIN 2 RECEPTOR ANTAGONIST;
ANTIHYPERTENSIVE AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
CILAZAPRIL;
CYCLOSPORIN A;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
HYDRALAZINE;
HYDROCHLOROTHIAZIDE;
IMMUNOSUPPRESSIVE AGENT;
LACIDIPINE;
RESERPINE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTERIAL PRESSURE;
BLOOD PRESSURE;
CHEMOPROPHYLAXIS;
CONTROLLED STUDY;
DISEASE MODEL;
EDITORIAL;
GLOMERULOPATHY;
GLOMERULOSCLEROSIS;
GLOMERULUS CAPILLARY;
GLOMERULUS FILTRATION RATE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEMODYNAMICS;
HOMEOSTASIS;
HYDROSTATIC PRESSURE;
IMMUNOREACTIVITY;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY TRANSPLANTATION;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN RESTRICTION;
PROTEINURIA;
RAT;
RAT STRAIN;
RENOVASCULAR HYPERTENSION;
TREATMENT OUTCOME;
|
EID: 0035142674
PISSN: 09310509
EISSN: None
Source Type: Journal
DOI: 10.1093/ndt/16.2.213 Document Type: Editorial |
Times cited : (11)
|
References (20)
|